Synergistic Vascular Disease Diagnosis System

A comprehensive system integrating AI, IoT, blockchain, and new materials to provide accurate and personalized vascular disease diagnosis and treatment recommendations.

The original patent disclosed a method for diagnosing vascular disease using a vascular disease diagnosing apparatus. However, the diagnosis method relied solely on the apparatus and did not leverage the potential of emerging technologies. The new inventive concept addresses this limitation by integrating distinct technologies to create a more powerful and accurate system.

The Synergistic Vascular Disease Diagnosis System comprises an AI-powered processor, a blockchain-based data storage unit, IoT-enabled sensors, and a vascular disease diagnosing apparatus incorporating new material-based sensors. The AI-powered processor integrates data from the vascular disease diagnosing apparatus, IoT-enabled sensors, and blockchain-based data storage unit to provide a comprehensive diagnosis. The system can also utilize a blockchain-based genetic database to store genetic information of patients and integrate it with machine learning algorithms to provide personalized diagnosis and treatment recommendations.

The new inventive concept integrates AI, IoT, blockchain, and new materials in a synergistic manner, which is not obvious from the original patent. The use of blockchain-based data storage and genetic database, IoT-enabled sensors, and new material-based sensors provides a novel and non-obvious solution for vascular disease diagnosis.

Alternative embodiments of the Synergistic Vascular Disease Diagnosis System could include the use of different AI algorithms, IoT protocols, or blockchain platforms. Variations of the system could also be designed for specific types of vascular diseases or patient populations.

The Synergistic Vascular Disease Diagnosis System has significant commercial potential in the healthcare industry, particularly in the fields of cardiology, vascular surgery, and personalized medicine. The system's ability to provide accurate and personalized diagnosis and treatment recommendations could lead to improved patient outcomes, reduced healthcare costs, and increased market share for healthcare providers and medical device manufacturers.